Cite
Paganetti H, Moteabbed M, Athar B, et al. SU-E-T-258: Assessment of Radiation Induced Second Cancer Risks in Proton Therapy and IMRT for Organs inside the Main Radiation Field. Med Phys. 2012;39(6):3762-3763doi: 10.1118/1.4735325.
Paganetti, H., Moteabbed, M., Athar, B., Adams, J., Schneider, U., & Yock, T. (2012). SU-E-T-258: Assessment of Radiation Induced Second Cancer Risks in Proton Therapy and IMRT for Organs inside the Main Radiation Field. Medical physics, 39(6), 3762-3763. https://doi.org/10.1118/1.4735325
Paganetti, H, et al. "SU-E-T-258: Assessment of Radiation Induced Second Cancer Risks in Proton Therapy and IMRT for Organs inside the Main Radiation Field." Medical physics vol. 39,6 (2012): 3762-3763. doi: https://doi.org/10.1118/1.4735325
Paganetti H, Moteabbed M, Athar B, Adams J, Schneider U, Yock T. SU-E-T-258: Assessment of Radiation Induced Second Cancer Risks in Proton Therapy and IMRT for Organs inside the Main Radiation Field. Med Phys. 2012 Jun;39(6):3762-3763. doi: 10.1118/1.4735325. PMID: 28517309.
Copy
Download .nbib